Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
journal
|
October 2014 |
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
|
journal
|
June 1998 |
Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2
|
journal
|
July 2013 |
Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line
|
journal
|
October 2002 |
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
|
journal
|
November 2011 |
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
|
journal
|
February 2014 |
Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
|
journal
|
May 2013 |
Structural specializations of α 4 β 7 , an integrin that mediates rolling adhesion
|
journal
|
January 2012 |
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection
|
journal
|
November 2014 |
Distinct Mechanisms Regulate Exposure of Neutralizing Epitopes in the V2 and V3 Loops of HIV-1 Envelope
|
journal
|
August 2014 |
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
|
journal
|
April 2012 |
Structure of a V3-Containing HIV-1 gp120 Core
|
journal
|
November 2005 |
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
|
journal
|
June 1998 |
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
|
journal
|
January 2013 |
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
|
journal
|
September 2012 |
PHENIX : building new software for automated crystallographic structure determination
|
journal
|
October 2002 |
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals
|
journal
|
June 2012 |
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies
|
journal
|
May 2011 |
Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7
|
journal
|
May 2012 |
XDS
|
journal
|
January 2010 |
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold
|
journal
|
September 2010 |
Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA
|
journal
|
July 2011 |
Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
|
journal
|
July 2010 |
HIV-1 Envelope Subregion Length Variation during Disease Progression
|
journal
|
December 2010 |
Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.
|
journal
|
January 1993 |
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.
|
journal
|
January 1987 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
|
journal
|
September 2009 |
Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIVSF162P4
|
journal
|
January 2010 |
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
|
journal
|
January 2013 |
Estimated Secondary Structure Propensities within V1/V2 Region of HIV gp120 Are an Important Global Antibody Neutralization Sensitivity Determinant
|
journal
|
April 2014 |
HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells
|
journal
|
February 2008 |
ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation
|
journal
|
May 1994 |
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.
|
journal
|
January 1994 |
A Twin-Cysteine Motif in the V2 Region of gp120 Is Associated with SIV Envelope Trimer Stabilization
|
journal
|
July 2013 |
Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus Particles
|
journal
|
April 2005 |
Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope
|
journal
|
August 2014 |
Protein modules and signalling networks
|
journal
|
February 1995 |
Complete Nucleotide Sequences of Functional Clones of the AIDS Virus
|
journal
|
January 1987 |
Functional Implications of the Binding Mode of a Human Conformation-Dependent V2 Monoclonal Antibody against HIV
|
journal
|
January 2014 |
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
|
journal
|
December 2002 |
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
|
journal
|
June 1990 |
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |